SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-15-033485
Filing Date
2015-04-10
Accepted
2015-04-10 08:46:05
Documents
1
Period of Report
2015-04-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3949
  Complete submission text file 0001209191-15-033485.txt   5437
Mailing Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142 (617) 500-7867
Aegerion Pharmaceuticals, Inc. (Issuer) CIK: 0001338042 (see all company filings)

IRS No.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VIVUS, INC. 1172 CASTRO STREET MOUNTAIN VIEW CA 94040
Business Address
Plutzky Jorge MD (Reporting) CIK: 0001576525 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34921 | Film No.: 15762655